KPTI - Karyopharm Therapeutics Inc.
8.77
-0.050 -0.570%
Share volume: 725,196
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$8.82
-0.05
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-06-2024 | 11-05-2024 | 02-19-2025 | 05-12-2025 | 08-11-2025 | 11-03-2025 | 02-13-2026 | |
| Assets | |||||||||
| Total Assets | 204.458 M | 213.977 M | 189.476 M | 164.418 M | 127.711 M | 104.879 M | 96.232 M | 108.416 M | |
| Current Assets | 198.366 M | 208.540 M | 184.755 M | 156.492 M | 120.238 M | 97.870 M | 89.746 M | 103.146 M | |
| Inventories | 2.769 M | 3.476 M | 4.672 M | 4.739 M | 4.769 M | 4.992 M | 3.966 M | 4.038 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 117.950 M | 67.350 M | 60.698 M | 46.236 M | 31.158 M | 12.972 M | 8.205 M | 3.204 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 30.628 M | 84.774 M | 72.828 M | 62.476 M | 38.783 M | 38.725 M | 37.672 M | 60.540 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 719.000 K | 628.000 K | 495.000 K | 400.000 K | 322.000 K | 244.000 K | 122.000 K | 104.000 K | |
| Other Assets | 5.373 M | 4.809 M | 4.226 M | 7.526 M | 7.151 M | 6.765 M | 6.364 M | 5.166 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 204.458 M | 213.977 M | 189.476 M | 164.418 M | 127.711 M | 104.879 M | 96.232 M | 108.416 M | |
| Total liabilities | 373.413 M | 346.117 M | 349.123 M | 350.435 M | 333.595 M | 343.805 M | 365.490 M | 401.342 M | |
| Total current liabilities | 65.341 M | 57.619 M | 61.493 M | 92.264 M | 90.370 M | 99.216 M | 87.157 M | 92.060 M | |
| Accounts Payable | 5.028 M | 2.797 M | 5.783 M | 5.107 M | 5.872 M | 2.597 M | 5.392 M | 4.003 M | |
| Other liabilities | 136.945 M | 170.622 M | 193.521 M | 163.568 M | 148.028 M | 155.023 M | 170.192 M | 193.370 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 171.127 M | 117.876 M | 94.109 M | 94.603 M | 95.197 M | 89.566 M | 108.141 M | 115.912 M | |
| Other liabilities | 136.945 M | 170.622 M | 193.521 M | 163.568 M | 148.028 M | 155.023 M | 170.192 M | 193.370 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -168.955 M | -132.140 M | -159.647 M | -186.017 M | -205.884 M | -238.926 M | -269.258 M | -292.926 M | |
| Common stock | 1.356 B | 1.369 B | 1.373 B | 1.378 B | 1.381 B | 1.385 B | 1.388 B | 1.467 B | |
| Retained earnings | -1.524 B | -1.501 B | -1.533 B | -1.563 B | -1.587 B | -1.624 B | -1.657 B | -1.759 B |